PMC:7195088 / 23217-23353 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"e but still to be peer reviewed [30] • Comparison of favipiravir vs. tocilizumab vs. favipiravir plus tocilizumab in patients with COVID","divisions":[{"label":"label","span":{"begin":37,"end":38}}],"tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T114","span":{"begin":18,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0008416"},{"id":"T115","span":{"begin":18,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0050081"}],"attributes":[{"subj":"T114","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T115","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T275","span":{"begin":53,"end":64},"obj":"Chemical"},{"id":"T276","span":{"begin":69,"end":80},"obj":"Chemical"},{"id":"T277","span":{"begin":85,"end":96},"obj":"Chemical"},{"id":"T278","span":{"begin":102,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A275","pred":"chebi_id","subj":"T275","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A276","pred":"chebi_id","subj":"T276","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A277","pred":"chebi_id","subj":"T277","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A278","pred":"chebi_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"subj":"T275","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T276","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T277","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T278","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#93d4ec","default":true},{"id":"LitCovid-PD-CHEBI","color":"#ecea93"}]}]}}